Your browser doesn't support javascript.
loading
Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.
McCracken, James T; Anagnostou, Evdokia; Arango, Celso; Dawson, Geraldine; Farchione, Tiffany; Mantua, Valentina; McPartland, James; Murphy, Declan; Pandina, Gahan; Veenstra-VanderWeele, Jeremy.
Afiliação
  • McCracken JT; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA 90024, United States. Electronic address: jmccracken@mednet.ucla.edu.
  • Anagnostou E; Department of Pediatrics, University of Toronto, Toronto, Canada.
  • Arango C; Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Univesitario Gregorio Maranon, and School of Medicine, Universidad Complutense de Madrid, CIBERSAM, Madrid, Spain.
  • Dawson G; Duke University Medical Center, Durham, North Carolina, United States.
  • Farchione T; Food and Drug Administration, Silver Spring, Maryland, United States.
  • Mantua V; Food and Drug Administration, Silver Spring, Maryland, United States.
  • McPartland J; Yale Child Study Center, New Haven, Connecticut, United States.
  • Murphy D; Institute of Psychiatry, Psychology and Neuroscience, King's College De Crespigny Park, Denmark Hill, London SE5 8AF, United Kingdom.
  • Pandina G; Neuroscience Therapeutic Area, Janssen Research & Development, Pennington, New Jersey, United States.
  • Veenstra-VanderWeele J; Department of Psychiatry, Columbia University, New York, NY, United States.
Eur Neuropsychopharmacol ; 48: 3-31, 2021 07.
Article em En | MEDLINE | ID: mdl-34158222

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Espectro Autista Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Neuropsychopharmacol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno do Espectro Autista Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Eur Neuropsychopharmacol Ano de publicação: 2021 Tipo de documento: Article